OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases
Authors:
- 8 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 79 (9) , 959-965
Abstract
Mesenchymal chondrosarcoma (MC) is a rare aggressive mesenchymal sarcoma. Specific markers for the differential diagnosis of MCs remain to be developed. OLIG2 expression has been reported only in neuroepithelial tumors. Recently, OLIG2 expression was found to be involved in the development of NCOA2 fusion-positive alveolar rhabdomyosarcomas. Therefore, we investigated whether OLIG2 expression could be used as a diagnostic marker for MC. We report the clinical pathological and immunohistochemical features of 14 MCs. All tumors showed typical pathological features including biphasic patterns with sheets of primitive round mesenchymal cells and interspersed islands of cartilage. These tumors expressed BCL2, SOX9, and CD99. OLIG2 was robustly expressed in 12/14 of MCs. NCOA2 rearrangement was found in 12 cases. OLIG2 expression was not found in the NCOA2 rearrangement-negative MCs. Notably, OLIG2 expression was not detected in 52 neoplasms (8 Ewing sarcomas, 23 hemangiopericytomas, and 21 chondrosarcomas) that are frequently misdiagnosed as MC. Our findings provide convincing evidence that OLIG2 can serve as a reliable marker in the differential diagnosis of MC and may be a unique neurodevelopmental gene expression signature for the NCOA2 rearranged MCs.Keywords
This publication has 20 references indexed in Scilit:
- Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and RelapseCancer Cell, 2019
- OLIG2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcomaHuman Pathology, 2019
- Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective ReviewSarcoma, 2015
- Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platformsTumor Biology, 2014
- Central neurocytoma with ependymoma-like glial componentBrain Tumor Pathology, 2014
- Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcomaOncology Reports, 2014
- Olig2‐positive cells in glioneuronal tumors show both glial and neuronal characters: The implication of a common progenitor cell?Neuropathology, 2012
- Expression of transcription factors during oligodendroglial developmentMicroscopy Research and Technique, 2001
- Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 casesCancer, 1986
- Unusual benign and malignant chondroid tumors of bone.A survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromasCancer, 1959